Published in Pol Arch Med Wewn on January 01, 2010
Measurement and Correlation of Indices of Insulin Resistance in Patients on Peritoneal Dialysis. Perit Dial Int (2015) 0.77
Effect of Short-term Erythropoietin Therapy on Insulin Resistance and Serum Levels of Leptin and Neuropeptide Y in Hemodialysis Patients. Indian J Endocrinol Metab (2017) 0.75
Methods of central vascular access for haemodialysis. Anaesthesiol Intensive Ther (2013) 0.97
Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension. Arch Med Sci (2010) 0.95
Psychological aspects of dialysis: does cognitive appraisal determine the overall outcome? Pol Arch Med Wewn (2010) 0.93
Age-related differences in the quality of life in end-stage renal disease in patients enrolled in hemodialysis or continuous peritoneal dialysis. Med Sci Monit (2013) 0.84
[Influence of controlled hypotensive therapy on renal autoregulation efficiency in the doppler captopril test in patients with chronic glomerulonephritis]. Pol Merkur Lekarski (2008) 0.83
Renal autoregulation in medical therapy of renovascular hypertension. Arch Med Sci (2010) 0.83
The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid. Pol Arch Med Wewn (2009) 0.82
Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report. Pol Arch Med Wewn (2009) 0.82
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome]. Pol Merkur Lekarski (2008) 0.81
Albuminuria and hyperhomocysteinemia as cardiovascular risk factors in potentially healthy soldiers: A long-term observation. Med Sci Monit (2012) 0.80
Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome. Arch Med Sci (2012) 0.79
Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease. Med Sci Monit (2013) 0.79
[Severe nephrotic syndrome requiring bilateral renal arteries embolisation in patient with membranous and diabetic nephropathy]. Pol Merkur Lekarski (2008) 0.79
Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration. Kardiol Pol (2013) 0.79
Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment. Pol Arch Med Wewn (2009) 0.79
[Cinacalcet in the therapy of secondary hyperparathyroidism--own experiences]. Pol Merkur Lekarski (2008) 0.78
[Usefulness of ultrasonographic renal resistive index in monitoring efficacy of hypotensive in haemodialysed patients--case report]. Pol Merkur Lekarski (2002) 0.78
[Advances in diagnosis and treatment of AL amyloidosis]. Pol Merkur Lekarski (2008) 0.77
Modified programme of in-patient (phase I) cardiac rehabilitation after acute myocardial infarction. Int J Rehabil Res (2002) 0.77
Acute kidney failure complicating carbon monoxide poisoning. Anaesthesiol Intensive Ther (2012) 0.76
The Balbiani body and generation of early asymmetry in the oocyte of a tiger beetle. Differentiation (2003) 0.75
Multiple renal abscesses leading to nephrectomy of the solitary kidney in a young female with type 1 diabetes and history of recurrent urinary tract infections. Arch Med Sci (2011) 0.75
Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy. Contemp Oncol (Pozn) (2012) 0.75
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]. Pol Merkur Lekarski (2008) 0.75
[Nephrotic syndrome in the course of primitive neuroectodermal tumor--case report]. Pol Merkur Lekarski (2008) 0.75
[Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker]. Pol Merkur Lekarski (2008) 0.75
[Spiral computed tomography in evaluation of arteriovenous fistula for hemodialysis. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
["Abdominal catastrophe" in peritoneal dialysis]. Pol Merkur Lekarski (2004) 0.75
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Pol Merkur Lekarski (2004) 0.75
Artificial neural network as the tool in prediction rheological features of raw minced meat. Acta Sci Pol Technol Aliment (2012) 0.75
Translumbar inferior vena cava cannulation. Anestezjol Intens Ter (2011) 0.75
[Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer]. Pol Merkur Lekarski (2008) 0.75
[Pseudoaneurysms after femoral arteries cannulations in hemodialysed patients--preliminary data]. Pol Merkur Lekarski (2004) 0.75
[Report of the activities of Warsaw-Lodz Branch of the Polish Society of Nephrology 1995-2001]. Pol Arch Med Wewn (2002) 0.75
[Pseudoaneurysm of arteriovenous fistula for haemodialysis]. Pol Merkur Lekarski (2002) 0.75
Aberrant function and differentiation of monocytes in end stage renal disease. Arch Immunol Ther Exp (Warsz) (2012) 0.75
Incidentally recognised thyroid focal uptake of 99mTc-sestamibi during stress myocardial perfusion scintigraphy. Endokrynol Pol (2015) 0.75
[Empirical therapy of peritonitis in peritoneal dialysis patients--it is reasonable to use a new therapeutic schedule?]. Pol Merkur Lekarski (2002) 0.75
Acute pancreatitis due to an attack of acute intermittent porphyria. Pol Arch Intern Med (2017) 0.75
[Vascular access for hemodialysis--own experiences]. Pol Merkur Lekarski (2008) 0.75
[Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care]. Pol Merkur Lekarski (2004) 0.75
[Renal resistive index--does it extend diagnostic possibilities in nephrology?]. Pol Merkur Lekarski (2004) 0.75
[Endovascular management of superior vena cava syndrome prior to arterio-venous fistula creation in patient treated by repeated haemodialysis]. Kardiol Pol (2013) 0.75
[Chlamydia pneumoniae antibodies and other atherosclerosis risk factors in haemodialysed patients. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
[Quality of life in dialysed patients--methodological issues]. Pol Merkur Lekarski (2002) 0.75
[Transperitoneal transport of water and substances--between theory and practice]. Pol Merkur Lekarski (2006) 0.75
[Translumbar cannulation of vena cava inferior as an alternative method of vascular access for hemodialysis]. Pol Merkur Lekarski (2008) 0.75
Atypical clinical presentation of Churg-Strauss syndrome with rapidly progressive glomerulonephritis: case report. Pol Arch Med Wewn (2009) 0.75
[Surveyed pregnant women's opinion concerning the importance of the participation in the school of birth as a form of preparation for childbirth]. Przegl Lek (2014) 0.75
[Mood and illness-related stress in dialysed patients]. Pol Merkur Lekarski (2002) 0.75
[Microalbuminuria and atherosclerosis risk factors in potentially healthy men--preliminary data]. Pol Merkur Lekarski (2004) 0.75
[Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis]. Pol Merkur Lekarski (2004) 0.75
Efficacy of peritoneal dialysis during infusion and drainage procedures. Perit Dial Int (2010) 0.75
[Diagnostic and therapeutical progress in malnutrition of patients with chronic renal failure]. Pol Merkur Lekarski (2004) 0.75
[Ambulatory or home peritoneal dialysis--time for changes?]. Pol Merkur Lekarski (2008) 0.75
[Encapsulating peritoneal sclerosis as a serious complication of peritoneal dialysotherapy--current opinions on treatment and prevention]. Pol Merkur Lekarski (2004) 0.75
[Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis]. Pol Merkur Lekarski (2008) 0.75
[Bacteremic shock in the course of urinary tract infection--case report]. Pol Merkur Lekarski (2004) 0.75
[Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy]. Pol Merkur Lekarski (2008) 0.75
[Influence of parathormone level on the doses of human recombinant erythropoietin in haemodialysed patients]. Pol Merkur Lekarski (2002) 0.75
[Spiral computed tomography angiography--advantages and limitations in nephrology and dialysotherapy]. Pol Merkur Lekarski (2002) 0.75
[Renal osteodystrophy as a cause of false positive result of whole body scintigraphy in a patient with differentiated thyroid cancer]. Pol Merkur Lekarski (2004) 0.75
Pulmonary physiotherapy in patients with bronchial asthma. Adv Exp Med Biol (2013) 0.75
[Effectiveness of subcutaneous and intravenous epoetin alpha in haemodialysed patients]. Pol Merkur Lekarski (2004) 0.75
[The analysis of the uterine cervix biocenosis in pregnant women]. Ginekol Pol (2007) 0.75
[Comparison of peritoneal transport of solutes and water during CAPD with glucose or amino acids solutions. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
New Options of Apheresis in Renal Diseases: How and When? Blood Purif (2015) 0.75
Low back pain in adolescents. An assessment of the quality of life in terms of qualitative and quantitative pain variables. J Back Musculoskelet Rehabil (2015) 0.75
[Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement]. Pol Merkur Lekarski (2008) 0.75
[Mathematical analysis of the possibilities of automated peritoneal dialysis optimization]. Pol Merkur Lekarski (2002) 0.75
[Mediastinal cyst in a patient on continuous ambulatory peritoneal dialysis successfully treated with video-assisted thoracic surgery (VATS)]. Pol Merkur Lekarski (2004) 0.75
[Atherosclerotic or hypertensive nephropathy--case report]. Pol Merkur Lekarski (2004) 0.75
[Report from the World Congress of Nephrology--Berlin 8-12 June 2003]. Pol Merkur Lekarski (2004) 0.75
Efficacy of automated peritoneal dialysis: from minimum to optimum. Pol Merkur Lekarski (2003) 0.75
[Value of multidetector computed tomography and digital subtraction angiography in assessment of arterio-venous fistula for hemodialysis--own experiences]. Pol Merkur Lekarski (2004) 0.75
Ketamine affects in vitro differentiation of monocyte into immature dendritic cells. Anesthesiology (2015) 0.75
[Asymptomatic intraperitoneal adhesions disease as the potential cause of unfeasibility of creation dialysis access to peritoneal cavity--case reports]. Pol Merkur Lekarski (2008) 0.75